Fas-CD40 chimera (Autolus Therapeutics)

N/A

Report date: 2025/06/11 10:27:30

Base Information

Drug NameFas-CD40 chimera (Autolus Therapeutics)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionApoptosis inhibitorsApoptosis-mediating surface antigen FAS modulators
TargetsApoptosis-mediating surface antigen FAS
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAutolus Therapeutics Plc
China Registration ClassN/A

Develop Information

Active CompaniesAutolus Therapeutics Plc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A